Macquarie target reduced to $3.80 from $3.90 and rated Outperform.
- Forums
- ASX - By Stock
- EML
- Ann: 2022 Interim Report
Ann: 2022 Interim Report, page-64
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.5¢ |
Change
0.005(0.76%) |
Mkt cap ! $247.7M |
Open | High | Low | Value | Volume |
66.0¢ | 66.5¢ | 64.5¢ | $315.3K | 480.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 4199 | 66.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.5¢ | 73414 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 8116 | 0.660 |
4 | 35740 | 0.655 |
5 | 92360 | 0.650 |
7 | 52476 | 0.645 |
7 | 43180 | 0.640 |
Price($) | Vol. | No. |
---|---|---|
0.665 | 73447 | 12 |
0.670 | 169561 | 5 |
0.675 | 30617 | 6 |
0.680 | 11000 | 2 |
0.685 | 24417 | 3 |
Last trade - 13.35pm 18/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online